retatrutide clinical trials safety RETATRUTIDE: The “Next Big Fat Loss Peptide” — But Here's What You NEED To Know 👀💉 is one of the newest peptides being talked about in the fitness and weight loss Retatrutide for weight loss: Study

Injectable Semaglutide has not been evaluated by the FDA, but side effects are expected to be similar to other Semaglutide-based medications reviewed by the FDA, which have the following side effects: nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar), flatulence (gas buildup), gastroenteritis (an intestinal infection), and gastroesophageal reflux disease (a type of digestive disorder)

Clinicians are aware of this and may monitor for gallbladder symptoms if patients lose weight very fast

Regev, L

These results align with the findings of Wang et al., 28 who reported a reduced incidence of liver cancer among individuals treated with GLP-1 receptor agonists